Group Education Helps Smoking Cessation and Hypertension Control
NCT ID: NCT05530083
Last Updated: 2022-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
2000 participants
INTERVENTIONAL
2022-10-12
2027-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using a General Health Promotion Approach to Help Smokers With Chronic Diseases Quit
NCT04037696
Testing Different Theories of Smoking Cessation: An Intervention Study
NCT01209897
Promoting Smoking Cessation in Campus
NCT05777005
Use of the Motivational Interviewing in the Treatment of Smokers in Groups in Primary Health Care
NCT03221010
School-EduSmoke: A Cluster Randomized Controlled Trial for Promoting Smoking Cessation Among Parents of Schoolchildren
NCT06853483
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group education
The investigators will provide experimental groups with group education of smoking cessation, including lectures in groups of 50 to 100 people and panel discussion in groups of 5 to 10 people.
group education
Group education is one of strategies and behavioural interventions of smoking cessation. Lectures, group meeting for mutual support, discussion of coping skills and suggestions for prevention relapse can help smokers quit smoking by providing support and encouragement from people in same condition.
conventional smoking cessation management
The investigators will provide control groups with conventional smoking cessation management, including regular follow-up of smoking status and giving advice of smoking cessation.
conventional smoking cessation management
Including regular follow-up of smoking status and giving advice of smoking cessation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
group education
Group education is one of strategies and behavioural interventions of smoking cessation. Lectures, group meeting for mutual support, discussion of coping skills and suggestions for prevention relapse can help smokers quit smoking by providing support and encouragement from people in same condition.
conventional smoking cessation management
Including regular follow-up of smoking status and giving advice of smoking cessation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 65 to 84
* new-onset hypertension or poorly controlled hypertension (140mmHg≤systolic blood pressure\<180mmHg and (or) 90mmHg≤ diastolic blood pressure\<110mmHg)
* smoked last week and smoked more than 1 cigarette per day on average
* be willing to quit smoking
* can communicate normally and cooperate in blood pressure measurements, finishing questionnaires
* complete interventions and follow-up consistently
Exclusion Criteria
* severe communication difficulties (aphasia, hearing impairment, etc.)
* suffering from mental disorders such as anxiety and depression
* cancer confirmed
* with previous serious cardiovascular events such as acute coronary syndrome, acute left heart failure, stroke or with specific cardiovascular therapeutic device such as pacemakers
* other serious physical illness or illness identified by investigators that unable to participant in study
* using specific non-permitted medication currently
65 Years
84 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Jiao Tong University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ji-Guang Wang
Director of the Shanghai Institute of Hypertension and the Department of Hypertension
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GESHC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.